United States Active Pharmaceutical Ingredient Market to Grow at an Impressive Rate of 9.73% through 2026
The growing uptake of biopharmaceuticals is expected to drive United States active pharmaceutical ingredient market through 2026 According to TechSci Research report, “ United States Active Pharmaceutical Ingredient Market By Method of Synthesis (Biological v/s. Synthetic), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Therapeutic Application (Cardiovascular Disease, Anti-diabetic, Oncology, Neurological Disorders, Musculoskeletal, Others), By Form (Tablet, Capsule, Injection, Others), By Molecule Type (Small v/s Large), By Potency (High v/s Low), By Drug Type (Innovator v/s Generic), By Region, Competition Forecast & Opportunities, 2016 – 2026” , the United States active pharmaceutical ingredient market stood at USD17.81 billion in 2020 and is projected to grow at a CAGR of 9.73% to cross USD31.48 billion by 2026. This can be accredited to the growing geriatric population across the country w...